Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Samyang Holdings Corporation (000070.KS)
Seoul, KR
Samyang Holdings Corporation, a diversified conglomerate founded in Seoul, South Korea, in 1924, engages in a wide array of activities through its various subsidiaries. The company's operations span the chemical, food, packaging, pharmaceutical, and IT service sectors. Its chemical division manufactures an extensive range of advanced materials, including value-added chemicals, terephthalic acid, various polycarbonate (PC) resins, bisphenol-A, and specialized engineering plastics. They also produce PC and polybutylene terephthalate compounds, PET bottles, and long fiber reinforced thermoplastics. In the food business, Samyang offers both health and wellness products and starch-based sugars. The company also extends into consumer services, operating the Seven Springs salad and brunch restaurant concept, along with Café Seven Springs bakeries. Its pharmaceutical arm develops and markets anti-cancer treatments such as Genexol and Nanoxel PM, in addition to medical devices like the NicoStop smoking cessation patch and biodegradable surgical sutures, including Trisorb and Monosorb. Samyang's products have a global reach, being exported to over 80 countries. Furthermore, Samyang provides comprehensive IT services, offering consulting for system management and integration, e-business solutions, and enterprise software (ERP, e-HR, MES, and mobile services) to clients in the public, finance, and manufacturing industries.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.33% | -3.93% | -14.95% | -18.04% | -49.36% | +2.81% | -7.42% | -20.81% | -47.91% | -62.68% | +210.50% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Conglomerates: +6.1%-5.8% Q1'26: -3.2% (vs Q1'25)
-
EPS growth Conglomerates: +16.9%-820.5% Q1'26: -6.7% (vs Q1'25)
-
FCF margin FCF growth · Conglomerates: +35.9%+0.5% Q1'26: -10.2% (vs Q1'25)
-
EBIT margin Conglomerates: +9.0%+3.3% Q1'26: +3.5% (vs Q1'25)
-
ROIC Conglomerates: +4.7%+3.4% Q1'26: +2.2% (vs Q1'25)
-
Share dilution Conglomerates: +0.0%+0.3% Q1'26: -9.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×6.08× Q1'26: 5.29× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
|---|---|---|---|---|---|---|---|
| Revenue |
2.18T
est: 2.18T (-0.1%)
|
2.31T
est: 2.28T (+1.4%)
|
2.40T
est: 2.37T (+1.1%)
|
2.56T
est: 2.53T (+1.4%)
|
2.49T
est: 2.60T (-4.4%)
|
2.47T
est: 2.63T (-5.9%)
|
3.11T
est: 2.65T (+17.2%)
|
| EBITDA |
176.73B
est: 248.41B (-28.9%)
|
223.69B
est: 259.84B (-13.9%)
|
175.39B
est: 270.16B (-35.1%)
|
215.48B
est: 288.16B (-25.2%)
|
203.72B
est: 296.81B (-31.4%)
|
268.75B
est: 299.52B (-10.3%)
|
460.98B
est: 302.30B (+52.5%)
|
| EBIT |
126.74B
est: 172.01B (-26.3%)
|
126.88B
est: 179.92B (-29.5%)
|
113.79B
est: 187.07B (-39.2%)
|
153.73B
est: 199.53B (-23.0%)
|
111.99B
est: 205.53B (-45.5%)
|
175.58B
est: 207.40B (-15.3%)
|
371.48B
est: 209.32B (+77.5%)
|
| Net Income |
46.49B
est: 56.83B (-18.2%)
|
22.61B
est: 63.14B (-64.2%)
|
37.68B
est: 54.45B (-30.8%)
|
69.97B
est: 78.08B (-10.4%)
|
62.04B
est: 93.14B (-33.4%)
|
102.31B
est: 100.68B (+1.6%)
|
237.70B
est: 106.87B (+122.4%)
|
| SGA |
152.85B
est: 167.36B (-8.7%)
|
158.79B
est: 175.06B (-9.3%)
|
172.80B
est: 182.02B (-5.1%)
|
178.15B
est: 194.15B (-8.2%)
|
184.31B
est: 199.98B (-7.8%)
|
173.20B
est: 201.80B (-14.2%)
|
189.30B
est: 203.67B (-7.1%)
|
| EPS |
6,011.00
est: 7,342.00 (-18.1%)
|
2,923.00
est: 8,157.00 (-64.2%)
|
4,871.00
est: 7,035.00 (-30.8%)
|
9,044.48
est: 10,088.00 (-10.3%)
|
8,018.43
est: 12,033.00 (-33.4%)
|
13,218.00
est: 13,008.00 (+1.6%)
|
30,712.00
est: 13,807.00 (+122.4%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-18 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-15 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-14 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-13 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-12 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-11 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Schwab Fundamental International Small Company Index ETF FNDC | 0.02% | 470.4K | 0.39% |
| 2 | Kodex KOSPI 226490.KS | 0.01% | 89.9K | 0.15% |
| 3 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 465.5K | 0.06% |
| 4 | Vanguard FTSE Pacific ETF VPL | 0.00% | 120.9K | 0.07% |
| 5 | Vanguard FTSE Developed Asia Pacific All Cap Index ETF VA.TO | 0.00% | 1.4K | 0.22% |
| 6 | Vanguard ESG International Stock ETF VSGX | 0.00% | 23.3K | 0.10% |
| 7 | Vanguard FTSE Developed All Cap ex North America Index ETF (CAD-hedged) VI.TO | 0.00% | 2.4K | 0.22% |
| 8 | Vanguard FTSE Developed All Cap ex North America Index ETF VIU.TO | 0.00% | 27.2K | 0.23% |
| 9 | Vanguard FTSE Developed All Cap ex U.S. Index ETF (CAD-hedged) VEF.TO | 0.00% | 3.2K | 0.22% |
| 10 | Vanguard FTSE Developed All Cap ex U.S. Index ETF VDU.TO | 0.00% | 2.0K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jeong Kim | President | — | male |
| Ji-Seop Kim | MD & Chief of Finance Officer | — | male |
| Tae-Ung Eom | Inside Director & Chief Executive Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 000070.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
